Quarterly report pursuant to Section 13 or 15(d)

Long-Term Debt and Other Financings (Tables)

v2.4.1.9
Long-Term Debt and Other Financings (Tables)
3 Months Ended
Mar. 31, 2015
Long-Term Debt and Other Financings [Abstract]  
Aggregate future principal and final fee payments of interest bearing obligations
Aggregate future principal, final payment fees and discounts of the Company’s total interest bearing obligations - long-term as of March 31, 2015 are as follows (in thousands):

Nine months ending December 31, 2015
 
$
15,140
 
Year ended 2016
   
9,037
 
Year ended 2017
   
14,659
 
Year ended 2018
   
17,843
 
     
56,679
 
Less: Interest, final payment fee and discount
   
(9,490
)
     
47,189
 
Less current portion
   
(15,605
)
   
$
31,584
 
Interest expense and amortization of debt issuance costs
Amortization of debt issuance costs and discounts are included in interest expense. Interest expense in the condensed consolidated statements of comprehensive loss for the three months ended March 31, 2015 and 2014 relates to the following debt instruments (in thousands):

   
Three Months Ended March 31,
 
   
2015
   
2014
 
   
   
 
GECC term loan
 
$
548
   
$
448
 
Servier loan
   
255
     
587
 
Hercules loan
   
234
     
-
 
Novartis note
   
78
     
77
 
Other
   
-
     
13
 
Total interest expense
 
$
1,115
   
$
1,125